Osama Mohamed Nabil

Mr. Osama Mohamed Nabil

The University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Mariusz SkwarczynskiMariusz Skwarczynski
Mariusz Skwarczynski
Sahra BashiriSahra Bashiri
Sahra Bashiri
YYYe Yuan
Ye Yuan
Zyta ZioraZyta Ziora
Zyta Ziora
Osama Mohamed NabilOsama Mohamed Nabil
Osama Mohamed Nabil
Istvan TothIstvan Toth
Istvan Toth
The development of effective treatments against infectious diseases is an extensive and ongoing process due to the rapid adaptation of bacteria to antibiotic-based therapies. However, appropriately designed activity enhancers, including antibiotic delivery systems, can increase the effectiveness of current antibiotics, overcoming antimicrobial resistance and decreasing the chance of contributing to further bacterial resistance. The activity/delivery enhancers improve drug absorption, allow targeted antibiotic delivery, improve their tissue and biofilm penetration and reduce side effects. This review provides insights into various antibiotic activity enhancers, including polymer, lipid, and silver-based systems, designed to reduce the adverse effects of antibiotics and improve formulation stability and efficacy against multidrug-resistant bacteria.